Thermo Fisher Scientific Inc. (TMO) operating KPIs
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)
Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%
Thermo Fisher Scientific đòn bẩy Nợ ròng / TTM Adjusted EBITDA (Net Debt / Adjusted TTM EBITDA) (×)
IR Financial Reconciliation Package (Page 12 Leverage Ratios)
Latest, FY2025
2.60
Period ended Dec 31, 2025
Change on a year earlier
+8.3%
2.40 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Đòn bẩy Nợ ròng / TTM Adjusted EBITDA (Net Debt / Adjusted TTM EBITDA) (×) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.60 | +8.3% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 2.40 | -4.0% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | 2.50 | +13.6% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2022 | Dec 31, 2022 | 2.20 | -4.3% | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2021 | Dec 31, 2021 | 2.30 | – | Q4 & FY2024 Reconciliation of Financial Information ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Đòn bẩy Nợ ròng / TTM Adjusted EBITDA (Net Debt / Adjusted TTM EBITDA) (×), annual FY2021–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/lev_net_debt_adj_ebitda_x
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.